BL- IMMUNOMODULATOR Flashcards

(43 cards)

1
Q

By________we mean the use of drugs, alone or in combination with other maneuvers, to change the function of all, or part, of the immune system

A

immunomodulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Immunomodulation Main categories

A
  1. Non-steroidal anti-inflammatory drugs (NSAIDs).
  2. Disease-modifying antirheumatic drugs (DMARDs).
  3. Glucocorticoids.
  4. Biological response modifiers.
  5. Tumor-specific monoclonal antibodies.
  6. Other antibodies.
  7. Miscellaneous drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The typical monoclonal antibody derives from the progeny of a single B cell, that has been fused with a multiple myeloma tumor cell; the resultant hybrid line can grow forever in culture like its tumor parent, but make the _______of its B cell parent.

A

specific antibody

~ 33 are already drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The first monoclonals were made using B cells directly derived from immunized mice; such antibodies are:

A

murine (mice)- e.g., ibritumomab

Most are made this way

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Monoclonal Antibodies definition

A

monospecific antibodies that are made by identical immune cells that are all clones of a unique parent cell, in contrast to polyclonal antibodies which are made from several different immune cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mouse Multiple Myeloma

A

These cells make antibodies and live “forever”

Now we can transform these (genetically) to make monoclonal ABs and be immortal

  • We deleted its light and heavy chain
  • We “fused” m.m.m w/ the cell we wanted creating a hybrid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

These are all examples of:

Non-steroidal anti-inflammatory drugs (NSAIDs). Disease-modifying antirheumatic drugs (DMARDs). Glucocorticoids. Biological response modifiers.Tumor-specific monoclonal antibodies. Other antibodies.

A

Immunomodulation Main categories

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

There are monoclonals which are ______-zumab

A

humanized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

We deleted its light and heavy chain

We “fused” m.m.m w/ the cell we wanted creating a hybrid

Why do this?

A

How we use Mouse Mult. Myeloma to make monoclonal ab’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Many of these agents are antibodies to various components of the immune or inflammatory system (which stimulate, inhibit, or opsonize, depending on the designer’s intentions).

A

BIOLOGICAL RESPONSE MODIFIERS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Do you use a B cell mmm hybride that sees self and tumor cell?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hybridoma

A

is a technology of forming hybrid cell lines (called hybridomas) by fusing an antibody-producing B cell with a myeloma (B cell cancer) cell that is selected for its ability to grow in tissue culture and for an absence of antibody chain synthesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Antibody to_______should be useful, and quite a few monoclonal antibodies (mAb) are already available

A

tumor-associated antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Do you use a B cell/mmm hybride that sees tumor cells but not self?

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Essential anti-inflammatories in transplantation. Usually start with very high
dose, taper as soon as possible; discontinue if possible. High doses can also be used briefly for threatened rejection episodes.

A

Glucocorticoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

is a technology of forming hybrid cell lines (called hybridomas) by fusing an antibody-producing B cell with a myeloma (B cell cancer) cell that is selected for its ability to grow in tissue culture and for an absence of antibody chain synthesis.

A

Hybridoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

agent decreases DNA synthesis and mRNA

transcription. It is gradually being replaced

A

Azathioprine (related to 6-mecaptopurine):

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

primary function is to decrease IL-2 production. Thus it is synergistic with
glucocorticoids which, by down-regulating macrophage function as APCs, lessen stimulation of
T cells.

A

Cyclosporine-A

19
Q

What is the problem with mouse monoclonal antibodies?

A

We react to the mouse protein
Make AB against it
So its better for one time use
(good for like transplants!)

20
Q

drug is less toxic and has the same mode of action as azathioprine

A

Mycophenolate mofetil.

21
Q

How can we improve mouse monoclonal antibodies so they can be used more than once?

A

Only need the variable region of the AB

Replace all else with human protein

Accomplish this with gene inserion into the Hybridoma

Creates Chimeric

*Can be used more than once

22
Q

HACA

A

Human anti-chimeric antibody. Eventually deveples against Chimeric

23
Q

Humanized monoclonal antibody only maintains ____ from the mouse antibody

24
Q

Only need the variable regionof the AB

Replace all else with human protein

Accomplish this with gene inserion into the Hybridoma

Creates______

25
HAHA
forms against humanized antibodies
26
Humira
Human antibody against tnf-alpha- Treats arthritis, ankylosing spondylitis, Crohn disease, or similar problems.
27
Humira is made by
Mouse with SCID given human thymus, bone marrow, and lymph mode. B cell against tnf-alpha found and used
28
-umab
Human monoclonal ab
29
-zumab
humanized monoclonal ab
30
Fully human mAb to TNFα. It has been shown to slow the progress of RA, and thus is a BRM and a DMARD, technically. Approvals: RA, JRA, psoriatic arthritis, ankylosing spondylitis, Crohn, ulcerative colitis, psoriasis
Humira
31
-ximab
Chimeric
32
Anti-IL-6 receptor. For use in ____when response to DMARDs is inadequate.
RA
33
Chimeric mAb to CD20. Used to treat non-Hodgkin’s lymphoma and chronic lymphocytic leukemia. For RA when anti-TNF therapy fails, and for Wegener’s granulomatosis. Off-label for MS.
rituximab
34
_______cells are large granular lymphocytes (LGL) which make up 5-10% of blood lymphocytic cells, with mechanisms available similar to those of CTL, but they do not have rearranged V(D)J genes and are not thymic-derived
NK (natural killer)
35
_______ are a type of cytotoxic lymphocyte critical to the innate immune system. Their role is analogous to that of cytotoxic T cells in the vertebrate adaptive immune response.
Natural killer cells or NK cells
36
NK cells can kill ______ cells, although you have never been exposed
Tumor cells, by virtue of their oddness
37
NK cells have _____ in the cytoplasm
GRANULES
38
NK (natural killer) cells are LARGE granular lymphocytes (LGL) which make up 5-10% of blood lymphocytic cells, with mechanisms available similar to those of CTL, but they do not have________ genes and are not thymic-derived
rearranged V(D)J
39
NK cells are part of the _____ immune system
innate
40
NK cells have receptors that attract them to
damaged or stressed cells, like tumor cells NK killing
41
NK has receptors for
the Fc portion of ABs | Antibody-dependent cell-mediated cytotoxicity, or ADCC
42
few NK receptors which recognize molecules on the surface of ‘stressed’ or dysregulated cells, such as virally infected cells or many tumors, which they then kill; therefore, they are part of the:
innate immune system
43
ADCC works because NK cells also have receptors for the Fc end of IgG (FcγR), and so they have an _______way to interact with target cells.
antibody-dependent